Диссертация (1139557), страница 47
Текст из файла (страница 47)
Res. – 2007.– Vol. 74. – P. 100–113.157. Maries L., Manitiu I. Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)// Cardiovasc. J Afr. – 2013. - Aug;24(7). – Р. 286-289.158. Marshall J.C. Inflammation, coagulopathy, and the pathogenesis of multiple organdysfunction syndrome// Crit. Care Med. - 2001. - Vol. 29.
- P. 99-106.159. Maruna P., Nedelnikova K., Gurlich R. Physiology and genetics of procalcitonin//Physiol. Res. – 2000. – Vol. 49(Suppl 1). – Р. 57–61.160. Masson S., Anand I., Favero C. et al. Serial measurement of cardiac troponin Tusing a highly sensitive assay in patients with chronic heart failure: data from 2 largerandomized clinical trials// Circulation. – 2012. - Jan 17;125(2) - Р.
280–288.161. McDonagh T.A., Holmer S., Raymond I. et al. NT – pro-BNP and the diagnosis ofheart failure: a pooled analysis of three European epidemiological studies// Eur. J. HeartFailure. – 2004. – Vol. 6. – Р. 269-273.162. McEvoy J.W., Chen Y., Ndumele C.E. et.al. Six-year change in high-sensitivitycardiac troponin t and risk of subsequent coronary heart disease, heart failure, and death//JAMA Cardiol. – 2016. - Aug 1;1(5) – Р. 519–528.163. Meisner M, Schmidt J, Huttner H, Tschaikowsky K.
The natural elimination rateof procalcitonin in patients with normal and impared renal function// Intensive Care Med.– 2000. – Vol. 26. – P. 212-16.309164. Mercier R.C., Rybak M.J., Bayer A.S., Yeaman M.R. Influence of platelets andplatelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an invitro model of infective endocarditis// Infect. Immun. – 2000.
- Aug;68(8). – Р. 4699705.165. Miguel-Bayarri V., Casanoves-Laparra E.B., Pallás-Beneyto L. et al. Prognosticvalue of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis// Med Intensiva. – 2012. - Nov;36(8). - Р.556-562.166.
Mocchegiani R., Nataloni M. Complications of infective endocarditis// Cardiovasc.Hematol. Disord. Drug Targets. – 2009. - Dec;9(4). – Р. 240-248.167. Monneret G., Pachot A., Laroche B. et al. Procalcitonin and calcitonin gene-relatedpeptide decrease LPS-induced TNF production by human circulating blood cells//Cytocine.
– 2000. – Vol. 12(6). – P. 762-764.168. Müller- Werdan U., Prondzinsky R., Werdan K. Effect of inflammatory mediatorson cardiovascular function// Curr. Opin. Crit. Care. – 2016. - Oct;22(5). - Р. 453-463.169. Murdoch D.R., Corey G.R., Hoen B. et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study// Arch. Intern. Med. – 2009. - Mar 9;169(5). - Р.463-473.170. Nakahara H., Song J., Sugimoto M.
et al. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis// Arthritis Rheum. – 2003. - Jun;48(6). - Р. 1521–1529.171. Nemeth E., Rivera S., Gabayan V., Keller C. et al. IL-6 mediates hypoferremia ofinflammation by inducing the synthesis of the iron regulatory hormone hepcidin// J. Clin.Invest. – 2004 - May;113(9). - Р. 1271–1276.172. Niebauer J. Endotoxins and immune activation in chronic heart failure: a prospective cohort study// Lancet. – 1999. – Vol.
353. – P. 1838-1842.173. Nishimoto N., Yoshizaki K., Tagoh H. et al. Elevation of serum interleukin 6 priorto acute phase proteins on the inflammation by surgical operation// Clin. Immunol. Immunopathol. – 1989. - Mar;50(3). - Р. 399–401.310174. Noman A., George J., Struthers A. A new use for B-type natriuretic peptide: todetect myocardial ischemia in non-heart failure patients// Br. J. Diabetes Vasc. Dis. –2010. – Vol. 10 - Р.
78–82.175. Nylen E.S., Whang K.T., Snider R.H. et al. Mortality is increased by procalcitoninand decreased by an antiserum reactive to procalcitonin in experimental sepsis// Crit. CareMed. – 1998. – Vol. 26 (6). – P. 1001–1006.176. Oberhoffer M., Russwurm S., Bredle D. et al. Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary timepoints// Intensive Care Med. – 2000.
- 26 (Suppl 2) - Р. 170–174.177. Okada M., Kitahara M., Kishimoto S. et al. IL-6/BSF-2 functions as a killer helperfactor in the in vitro induction of cytotoxic T cells// J. Immunol. – 1988. - Sep 1;141(5) Р. 1543–1549.178. Okada Y, Hosono M, Sasaki Y et al. Preoperative increasing C-reactive proteinaffects the outcome for active infective endocarditis// Ann.
Thorac. Cardiovasc. Surg. –2014. – Vol. 20(1). - Р. 48-54.179. Okamura Y. Usefulness of Presepsin Measurement: A New Biomarker for Sepsis//Rinsho Byori. – 2015. - Jan;63(1). - Р. 62-71.180. Okamura Y., Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST)// Clin. Chim. Acta. – 2011. – Vol. 412(23-24). – P.2153–2157.181. Opal S.M., van der Poll T. Endothelial barrier dysfunction in septic shock// J. Intern. Med.
– 2015. - Mar;277(3) - Р. 277-293.182. Orjalo A.V., Bhaumik D., Gengler В. K. et al. Cell surface-bound IL1 is an upstream regulator of the senescence-associated IL6/IL8 cytokine network// Proc. Natl.Acad. Sci. USA. -2009. - Vol. 106 (40). - P. 17031-17036.183. Palmiere C., Mussap M., Bardy D. et al. Diagnostic value of soluble CD14 subtype(sCD14-ST) presepsin for the postmortem diagnosis of sepsis-related fatalities// Int. J.Legal. Med. – 2013.
– Vol. 127. – P. 799 – 808.311184. Pantelidou I.M., Giamarellos-Bourboulis E.J. Can procalcitonin monitoring reducethe length of antibiotic treatment in bloodstream infections?// Int. J. Antimicrob. Agents.– 2015. - Dec;46 Suppl 1 - Р.10-12.185. Papp M., Tornai T., Vitalis Z. et al. Presepsin teardown - pitfalls of biomarkers inthe diagnosis and prognosis of bacterial infection in cirrhosis// World J. Gastroenterol. –2016. - Nov 7;22(41) – Р. 9172-9185.186.
Payen D., Faivre V., Lukaszewicz A. C., Losser M. R. Assessment of immunological status in the critically ill // Minerva Anest. - 2000. - Vol.66 (5). - P. 351-358.187. Pepys M. B., Hirschfield G. M. C-reactive protein: a critical update// J. Clin. Invest.- 2003. - Vol.111. - P. 1805-1812.188. Perry E.L., Flemming R.G., Edwards J.E. Myocardial lesions in subacute bacterialendocarditis. //Ann. Intern. Med.
– 1952. – Vol. 36. – P. 126 – 137.189. Picariello C., Lazzeri C., Valente S. et al. Kinetics of procalcitonin in cardiogenicshock and in septic shock. Preliminary data// Acute Card. Care. – 2010. - Sep;12(3). - Р.96-101.190. Pierce D., Calkins B.C., Thornton K. Infectious endocarditis: diagnosis andtreatment// Am. Fam. Physician.
– 2012. - Vol. 85 (10). – P. 981–986.191. Pruszczyk P., Kostrubiec M., Bochowicz A. et al. N-terminal pro-brain natriureticpeptide in patients with acute pulmonary embolism// Eur. Respir. J. – 2003. – Vol. 22. –P. 649-653.192. Ragnarsson S., Sjögren J., Stagmo M. et al. Clinical Presentation of Native MitralValve Infective Endocarditis Determines Long-Term Outcome after Surgery// J.
Card.Surg. – 2015. - Sep;30(9). - Р.669-676.193. Ramírez-Duque N., García-Cabrera E., Ivanova-Georgieva R. et al. Grupo para elEstudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de EnfermedadesInfecciosas. Surgical treatment for infective endocarditis in elderly patients// J. Infect.
–2011. - Aug;63(2). – Р. 131-138.312194. Ramsperger-Gleixner M., Spriewald B.M., Tandler R. et al. Increased transcriptlevels of TNF-α, TGF-β, and granzyme B in endomyocardial biopsies correlate with allograft rejection// Experimental and Clinical Transplantation. – 2011. – Vol. 9(6). – Р.387–392.195. Rawczynska-Englert I., Hryniewiecki T., Dzierzanowska D.
Evaluation of serumcytokine concentrations in patients with infective endocarditis// J. Heart Valve Dis. –2000. - Sep;9(5). – Р. 705-709.196. Reinhart K., Karzai W., Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection// Intensive Care Med. – 2000. - Sep;26(9). – Р. 11931200.197. Reinhart K., Meisner M. Biomarkers in the critically ill patient: procalcitonin //Crit. Care Clin. – 2011. – Vol.
27. – P. 253-63.198. Richards M., Di Somma S, Mueller C. et al. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from theBACH Study (Biomarkers in Aсute Heart Failure)// JACC Heart Fail. – 2013. – Vol. 1(3).– Р.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
